Marker Therapeutics annual debt-to-assets ratio
2010
2011
2012
2013
2018
2019
2020
2021
2022
Marker Therapeutics Debt-to-Assets Ratio Growth & History (MRKR)
Marker Therapeutics's debt-to-assets ratio was 0.22 for fiscal 2022.
View full Marker Therapeutics company overviewMarker Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | 0.22 | 0.05 | +26.70% |
| 2021 | 2021-12-31 | 0.17 | −0.09 | −35.00% |
| 2020 | 2020-12-31 | 0.27 | 0.26 | +2473.77% |
| 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| 2018 | 2018-12-31 | 0.00 | — | — |
| 2013 | 2013-12-31 | 41.05 | 24.15 | +142.94% |
| 2012 | 2012-12-31 | 16.90 | 13.96 | +475.52% |
| 2011 | 2011-12-31 | 2.94 | −0.10 | −3.18% |
| 2010 | 2010-12-31 | 3.03 | — | — |
Marker Therapeutics quarterly debt-to-assets ratio
Q4.10
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q3.13
Q4.13
Q1.14
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2023 | 2023-03-31 | 0.27 | 0.05 | +25.68% |
| Q4 2022 | 2022-12-31 | 0.22 | 0.05 | +26.70% |
| Q3 2022 | 2022-09-30 | 0.19 | 0.02 | +12.40% |
| Q2 2022 | 2022-06-30 | 0.22 | 0.07 | +46.59% |
| Q1 2022 | 2022-03-31 | 0.21 | 0.08 | +54.55% |
| Q4 2021 | 2021-12-31 | 0.17 | −0.09 | −35.00% |
| Q3 2021 | 2021-09-30 | 0.17 | −0.08 | −33.67% |
| Q2 2021 | 2021-06-30 | 0.15 | −0.04 | −22.87% |
| Q1 2021 | 2021-03-31 | 0.14 | 0.13 | +1260.40% |
| Q4 2020 | 2020-12-31 | 0.27 | 0.26 | +2473.77% |
| Q3 2020 | 2020-09-30 | 0.25 | 0.24 | +2327.72% |
| Q2 2020 | 2020-06-30 | 0.20 | 0.18 | +1752.67% |
| Q1 2020 | 2020-03-31 | 0.01 | −0.00 | −10.70% |
| Q4 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| Q3 2019 | 2019-09-30 | 0.01 | — | — |
| Q2 2019 | 2019-06-30 | 0.01 | — | — |
| Q1 2019 | 2019-03-31 | 0.01 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | — | — |
| Q1 2014 | 2014-03-31 | 3.97 | −8.17 | −67.29% |
| Q4 2013 | 2013-12-31 | 41.05 | 24.15 | +142.94% |
| Q3 2013 | 2013-09-30 | 15.66 | −3.84 | −19.71% |
| Q1 2013 | 2013-03-31 | 12.14 | 1.08 | +9.80% |
| Q4 2012 | 2012-12-31 | 16.90 | 13.96 | +475.52% |
| Q3 2012 | 2012-09-30 | 19.50 | 18.47 | +1792.71% |
| Q2 2012 | 2012-06-30 | 17.10 | 16.01 | +1473.92% |
| Q1 2012 | 2012-03-31 | 11.06 | — | — |
| Q4 2011 | 2011-12-31 | 2.94 | −0.10 | −3.18% |
| Q3 2011 | 2011-09-30 | 1.03 | — | — |
| Q2 2011 | 2011-06-30 | 1.09 | — | — |
| Q4 2010 | 2010-12-31 | 3.03 | — | — |
Marker Therapeutics debt-to-assets ratio trends
Between the periods ended 2010-12-31 and 2022-12-31, Marker Therapeutics's debt-to-assets ratio decreased from 3.03 to 0.22, a change of −2.81. The latest reported quarter, Q1 2023, shows 0.27.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marker Therapeutics source filings ↗